Literature DB >> 11290308

High frequency of colonization and absence of identifiable risk factors for methicillin-resistant Staphylococcus aureus (MRSA)in intensive care units in Brazil.

G P Korn1, M D Martino, I M Mimica, L J Mimica, P A Chiavone, L R Musolino.   

Abstract

Colonization of hospitalized patients with methicillin-resistant Staphylococcus aureus (MRSA) is of increasing concern. To evaluate this problem in Intensive Care Units (ICUs) in Brazil, we studied 100 patients admitted to two ICUs from April to June, 1997. Of the 100 patients, 70 were male, 53 were age 60 years or older, 55 were previously hospitalized, 78 were transferred to the ICU from other hospital units, 49 had received antibiotic therapy, and 66 had undergone recent surgery. Nasal and axillary swab cultures were obtained on admission and every 48 hours thereafter until discharge. MRSA were identified by plating any cultured S. aureus on Mueller-Hinton agar containing 6 microg/ml of oxacillin. At the time of admission, 46 (46%) of the patients were colonized with MRSA. No associated risk factors for acquiring MRSA (age, previous hospitalization, prior surgery) could be identified. Of the 54 patients negative for MRSA on admission, 28 (52%) became colonized while in the ICU. Sixteen (22%) of the 74 colonized patients (colonized either on admission or during ICU stay) had associated respiratory or urinary tract infections due to MRSA, and 9 (56%) died. No correlation with special risk factors (invasive procedures, antibiotic use, age, chronic disease) was identified. MRSA occurred frequently, but there was minimal evidence of associated risk factors. Thus, control of MRSA cannot be accomplished by targeting special factors alone, but requires attention to preventing microbial spread in all areas. Of special concern is the high frequency of acquiring the organism in the ICU (52%). Education concerning the importance of hand washing, environmental surface cleaning, and barrier protection from infected patients is needed.

Entities:  

Mesh:

Year:  2001        PMID: 11290308     DOI: 10.1590/s1413-86702001000100001

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  6 in total

1.  Genetic Lineages of Methicillin-Resistant Staphylococcus aureus Acquired during Admission to an Intensive Care Unit of a General Hospital.

Authors:  Wadha Alfouzan; Rita Dhar; Edet Udo
Journal:  Med Princ Pract       Date:  2016-11-08       Impact factor: 1.927

2.  Prevalence and acquisition of MRSA amongst patients admitted to a tertiary-care hospital in Brazil.

Authors:  Helena B Santos; Denise P Machado; Suzi A Camey; Ricardo S Kuchenbecker; Afonso L Barth; Mário B Wagner
Journal:  BMC Infect Dis       Date:  2010-11-14       Impact factor: 3.090

3.  Risk factors for infection with multidrug-resistant bacteria in non-ventilated patients with hospital-acquired pneumonia.

Authors:  Renato Seligman; Luis Francisco Ramos-Lima; Vivian do Amaral Oliveira; Carina Sanvicente; Juliana Sartori; Elyara Fiorin Pacheco
Journal:  J Bras Pneumol       Date:  2013 May-Jun       Impact factor: 2.624

4.  Elimination of Staphylococcus aureus nasal carriage in intensive care patients lowers infection rates.

Authors:  Leila Akhtar Danesh; Zeinab Saiedi Nejad; Hossein Sarmadian; Saeed Fooladvand; Alex van Belkum; Ehsanollah Ghaznavi-Rad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-12       Impact factor: 3.267

5.  Nosocomial infections in human immunodeficiency virus type 1 (HIV-1) infected and AIDS patients: major microorganisms and immunological profile.

Authors:  C Panis; T Matsuo; E M V Reiche
Journal:  Braz J Microbiol       Date:  2009-03-01       Impact factor: 2.476

6.  Staphylococcus aureus Isolates Carrying Panton-Valentine Leucocidin Genes: Their Frequency, Antimicrobial Patterns, and Association With Infectious Disease in Shahrekord City, Southwest Iran.

Authors:  Laleh Shariati; Majid Validi; Ali Mohammad Hasheminia; Reza Ghasemikhah; Fariborz Kianpour; Ali Karimi; Mohammad Reza Nafisi; Mohammad Amin Tabatabaiefar
Journal:  Jundishapur J Microbiol       Date:  2016-01-02       Impact factor: 0.747

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.